INTERFERON ALPHA-2A THERAPY FOR DISSEMINATED INTRAVASCULAR COAGULATION IN A PATIENT WITH BLUE RUBBER BLEB NEVUS SYNDROME - A CASE-REPORT

Citation
M. Kunishige et al., INTERFERON ALPHA-2A THERAPY FOR DISSEMINATED INTRAVASCULAR COAGULATION IN A PATIENT WITH BLUE RUBBER BLEB NEVUS SYNDROME - A CASE-REPORT, Angiology, 48(3), 1997, pp. 273-277
Citations number
13
Categorie Soggetti
Peripheal Vascular Diseas
Journal title
ISSN journal
00033197
Volume
48
Issue
3
Year of publication
1997
Pages
273 - 277
Database
ISI
SICI code
0003-3197(1997)48:3<273:IATFDI>2.0.ZU;2-C
Abstract
The authors present a sixteen-year-old girl with blue rubber bleb nevu s syndrome (BRBNS) associated with disseminated hemangiomas involving the skin, oral cavity, skeletal muscle, and cerebrum. Although she den ied neurologic symptoms, magnetic resonance imaging of the brain demon strated dilatated cerebral veins and the Chiari I malformation. Examin ation of hemostasis revealed disseminated intravascular coagulation (D IG) manifesting as Kasabach-Merritt syndrome, with the potential for l ife-threatening bleeding or thrombosis in the central nervous system. Since successful management of life-threatening hemangiomas with inter feron alpha-2a (IFN alpha-2a) has been reported, the authors administe red IFN alpha-2a with an improvement in hemostasis. These findings sug gest that IFN alpha-2a therapy is beneficial for relieving the life-th reatening consumptive coagulopathy associated with BRBNS.